Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Costentin

Showing results (151-160 of 244) with videos related to

Pageof 25
Sort By:
British Journal of Pharmacology|May 26, 2001
Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptakeM Syringas, F Janin, B Giros, et al.
Life Sciences|November 6, 2002
Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injectionC Le Cudennec, B Naudin, J-C Do Rego, et al.
European Journal of Pharmacology|August 1, 2000
SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptorM El Yacoubi, C Ledent, M Parmentier, et al.
Annales Pharmaceutiques Francaises|August 18, 2004
[Assessment of the in vitro and in vivo toxicity of 3,4-dihydroxyphenylacetaldehyde (DOPAL)]J-J Bonnet, H Legros, Fr Janin, et al.
Psychopharmacology|January 1, 1992
5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonistsP Simon, B Guardiola, J Bizot-Espiard, et al.
European Journal of Pharmacology|January 12, 1993
In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotionJ M Vaugeois, J J Bonnet, D Duterte-Boucher, et al.
Brain Research|November 29, 1986
Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphanA Coquerel, I Dubuc, J F Menard, et al.
Brain Research|June 15, 1999
Acute interactions between L-DOPA and the neurotoxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine in miceC Cleren, C Vilpoux, N Dourmap, et al.
Life Sciences|January 6, 2000
Comparison of behavioural effects of NocII or NocIII, two related pronociceptin-derived peptidesS Florin, F Leblond, C Suaudeau, et al.
Neuropharmacology|September 1, 1978
Modulation of receptor mechanisms in the CNS: hyper- and hyposensitivity to catecholaminesJ C Schwartz, J Costentin, M P Martres, et al.
Pageof 25

Showing results (151-160 of 244) with videos related to

Sort By:
Pageof 25
British Journal of Pharmacology|May 26, 2001
Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptakeM Syringas, F Janin, B Giros, et al.
Life Sciences|November 6, 2002
Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injectionC Le Cudennec, B Naudin, J-C Do Rego, et al.
European Journal of Pharmacology|August 1, 2000
SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptorM El Yacoubi, C Ledent, M Parmentier, et al.
Annales Pharmaceutiques Francaises|August 18, 2004
[Assessment of the in vitro and in vivo toxicity of 3,4-dihydroxyphenylacetaldehyde (DOPAL)]J-J Bonnet, H Legros, Fr Janin, et al.
Psychopharmacology|January 1, 1992
5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonistsP Simon, B Guardiola, J Bizot-Espiard, et al.
European Journal of Pharmacology|January 12, 1993
In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotionJ M Vaugeois, J J Bonnet, D Duterte-Boucher, et al.
Brain Research|November 29, 1986
Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphanA Coquerel, I Dubuc, J F Menard, et al.
Brain Research|June 15, 1999
Acute interactions between L-DOPA and the neurotoxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine in miceC Cleren, C Vilpoux, N Dourmap, et al.
Life Sciences|January 6, 2000
Comparison of behavioural effects of NocII or NocIII, two related pronociceptin-derived peptidesS Florin, F Leblond, C Suaudeau, et al.
Neuropharmacology|September 1, 1978
Modulation of receptor mechanisms in the CNS: hyper- and hyposensitivity to catecholaminesJ C Schwartz, J Costentin, M P Martres, et al.
Pageof 25